Paul Doan, AB - Publications

Affiliations: 
2018-2022 Molecular and Cellular Biology Harvard College 
 2020-2025 Medical Oncology Dana-Farber Cancer Institute, Boston, MA, United States 
Area:
cancer, cell biology, gastrointestinal, chemical biology

0/11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
Low-probability matches (unlikely to be authored by this person)
2022 Doan P, Scheltema MJ, Amin A, Shnier R, Geboers B, Gondoputro W, Moses D, van Leeuwen PJ, Haynes AM, Matthews J, Brenner P, O'Neill G, Yuen C, Delprado W, Stricker P, et al. Final analysis of the Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial. The Journal of Urology. 101097JU000000000000. PMID 35947521 DOI: 10.1097/JU.0000000000002885  0.01
2022 Geboers B, Gondoputro W, Thompson JE, Reesink DJ, van Riel LAMJG, Zhang D, Blazevski A, Doan P, Agrawal S, Matthews J, Haynes AM, Liu Z, Delprado W, Shnier R, de Reijke TM, et al. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Irreversible Electroporation-A Multicenter Validation Study. European Urology Focus. PMID 35577751 DOI: 10.1016/j.euf.2022.04.010  0.01
2022 Gondoputro W, Scheltema MJ, Blazevski A, Doan P, Thompson JE, Amin A, Geboers B, Agrawal S, Siriwardana AR, van Leeuwen PJ, van Oosterom MN, van Leeuwen FN, Emmett LM, Stricker PD. Robot-assisted prostate-specific membrane antigen-radioguided surgery in primary diagnosed prostate cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 35241483 DOI: 10.2967/jnumed.121.263743  0.01
2021 Doan P, Graham P, Lahoud J, Remmers S, Roobol MJ, Kim L, Patel MI. A comparison of prostate cancer prediction models in men undergoing both magnetic resonance imaging and transperineal biopsy: Are the models still relevant? Bju International. PMID 34374190 DOI: 10.1111/bju.15554  0.01
2021 Lahoud J, Doan P, Kim L, Patel MI. Perilesional Biopsies Increase Detection of Significant Prostate Cancer in Men with PI-RADS 4/5 Lesions: Validation of the PI-RADS Steering Committee Recommendation. European Urology. PMID 33593652 DOI: 10.1016/j.eururo.2021.01.039  0.01
2021 Doan P, Lahoud J, Kim L, Patel MI. Identifying prostate cancer in men with non-suspicious multi-parametric magnetic resonance imaging of the prostate. Anz Journal of Surgery. PMID 33475230 DOI: 10.1111/ans.16583  0.01
2021 Lahoud J, Doan P, Kim LH, Patel MI. Transperineal systematic biopsies in addition to targeted biopsies are important in the detection of clinically significant prostate cancer. Anz Journal of Surgery. PMID 33400371 DOI: 10.1111/ans.16524  0.01
2020 Kim LH, Doan P, He Y, Lau HM, Pleass H, Patel MI. A Systematic Review and Meta-Analysis of the Significance of Body Mass Index on Kidney Cancer Outcomes. The Journal of Urology. 101097JU000000000000. PMID 32945696 DOI: 10.1097/JU.0000000000001377  0.01
2019 Doan PN, Yip J, Wang H, Chia D, Kim LHC, Wang A. Case - Repair of extensive testicular rupture: A unique use for biosynthetic grafts. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. PMID 31670646 DOI: 10.5489/cuaj.6052  0.01
2008 Doan PS. Primary cutaneous malignant melanoma. Aviation, Space, and Environmental Medicine. 79: 919-21. PMID 18785363  0.01
2005 Doan PS. You're the flight surgeon. Melanoma. Aviation, Space, and Environmental Medicine. 76: 900-1. PMID 16173687  0.01
Hide low-probability matches.